Lv7
3680 积分 2023-11-07 加入
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
4个月前
已完结
Embracing cancer complexity: Hallmarks of systemic disease
4个月前
已完结
Immune thrombocytopenia: a review on the pathogenetic role of immune cells
4个月前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
5个月前
已完结
Telitacicept, a novel humanized, recombinant TACI-Fc fusion protein, for the treatment of systemic lupus erythematosus
5个月前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
7个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
8个月前
已完结
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157(V940)Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study
8个月前
已完结
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
9个月前
已完结
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
9个月前
已完结
皖公网安备34019202002308
